HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$12.16
Day range
$11.99 - $12.86
Year range
$9.00 - $22.33
Market cap
411.84M USD
Avg Volume
127.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.54M | 72.37% |
Net income | -14.19M | 2.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -14.82M | 1.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 121.47M | 57.06% |
Total assets | 139.81M | 44.02% |
Total liabilities | 26.27M | 5.10% |
Total equity | 113.54M | — |
Shares outstanding | 26.65M | — |
Price to book | 2.85 | — |
Return on assets | -38.49% | — |
Return on capital | -45.76% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -14.19M | 2.68% |
Cash from operations | -13.98M | 15.91% |
Cash from investing | -73.00K | 31.78% |
Cash from financing | 100.07M | 123,644.44% |
Net change in cash | 86.02M | 611.58% |
Free cash flow | -9.23M | — |
About
Founded
2017
Website
Employees
58